Not recruiting
Plasma cell myeloma
Not recruitingStudy Comparing Lenalidomide, Bortezomib, Dexamethasone, Isatuximab, and Iberdomide for Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplant
Registered drugNo placebo
Study Comparing Lenalidomide, Bortezomib, Dexamethasone, Isatuximab, and Iberdomide for Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplant
Registered drugNo placebo
- Disease:Plasma cell myeloma
- Substances:BortezomibDexamethasone+3
Countries:
Spain
Spain- Participants:18–64 years
- Substances:Bortezomib
